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Summary
In addition, a molecular model for RT1.Aa has been
built from the crystal structures of three human class I
Functional polymorphism in the rat peptide transporter MHC alleles (Thorpe et al., 1995). The resulting model
associated with antigen processing (TAP) changes the structure was used inpredictive peptide docking experi-
peptide pool available for binding and presentation by ments to define putative anchor residues. The peptide
a class I MHC allele, RT1.Aa. The peptide binding motif position 2 (P2) pocket of RT1.Aa was predicted to bind
for RT1.Aa, determined by stabilization with synthetic Leu or a similar hydrophobic residue, while the highly
peptides, included a strong preference for arginine at negatively charged C-terminal binding pocket formed
the peptide C terminus. Analysis of natural peptides by residues Asp77, Glu97, and Asp116 was predicted
bound to RT1.Aa by both pool sequencing and anhy- to bind Arg or Lys residues. Thus, the predicted peptide
drotrypsin chromatography revealed that TAP poly- motif requirement for RT1.Aa and the known in vitro
morphism determined the presence or absence of ar- peptide transport specificity of TAP2B-containing trans-
ginine as the peptide C-terminal residue. This result porters would appear to be discordant when RT1.Aa is
highlights the in vivo impact of TAP±peptide selectivity, expressed in cells carrying only these transporters.
and provides evidence against a high rate of genera- To establish whether this discordance is responsible
tion of new C termini by protease activity in the endo- for the cim effect, we have further investigated the pep-
plasmic reticulum. tide motif of this class I molecule, and analyzed the pool
of naturally bound peptides. We confirm the suggestion
from immunological studies that the cim effect is dueIntroduction
to the loading of different peptide sets, and that the
key variable is the presence or absence of a C-terminalMajor histocompatibility complex (MHC) class I mole-
arginine associated with the strong structural prefer-cules bind and present short peptides to CD81 T lym-
ence of RT1.Aa for this peptide C-terminal residue. Wephocytes of the immune system. These peptides, de-
also establish here that the limiting step in the supplyrived mostly from the degradation of cytosolic or nuclear
of peptides with the appropriate C terminus for class Iproteins (Hunt et al., 1992; Jardetzky et al., 1991), are
binding occurs at the level of TAP, suggesting a minortranslocated into the endoplasmic reticulum (ER) by the
role for protease activity in thegeneration of new peptidetransporter associated with antigen processing (TAP)
C termini in the ER.(Neefjes et al., 1993; Shepherd et al., 1993), a heterodim-
eric complex comprising two polypeptides (TAP1 and
ResultsTAP2), each a member of the ABC transporter family
To determine its peptide-binding motif experimentally,
RT1.Aa was transfected into the TAP2-defective mouse6 The first two authors contributed equally to this work.
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Figure 1. In Vitro Peptide Binding to RT1.Aa Expressed on RMA-S Cells
The large increase in the frequency of Arg at position 9 indicates that peptides with C-terminal Arg residues are strongly favored for binding
by RT1.Aa. The panels show the observed frequency of each amino acid in the 642 9-mer peptide set tested (open bars), compared with the
top 50 binding peptides (closed bars) as determined by flow cytometry.
cell line RMA-S (Townsend et al., 1989; Powis et al. and the modeling study agree over the importance of
1991a; Yang et al., 1992) to set up an in vitro cell surface the P9 Arg C-terminal anchor, while the in vitro peptide
stabilization assay. The expression of RT1.Aa when data for P2 and P7 suggest that both may play a role
transfected into RMA-S, like the endogenous class I in peptide binding by RT1.Aa.
molecules (Ljunggren et al., 1990; Schumacher et al., The motif information obtained by modeling and the
1990), is increased after incubation at 268C. Addition of stabilization assay was then compared with that derived
an appropriate exogenous peptide to these cells leads by sequencing pools of acid-eluted peptides (Falk et
to stabilization of these molecules at the cell surface, al., 1991) from RT1.Aa molecules affinity purified from
which can be detected by flow cytometry (Feltkamp et spleens of rat strains bearing TAP2A or TAP2B (PVG-
al., 1993). A panel of 642 synthetic 9-mer peptides was RT1av1 [DA] and PVG.R1, respectively). We hoped that
screened using this method. In three separate experi- information obtained from sequencing the naturally oc-
ments the 50 peptides that gave the largest increases curring pool of peptides could highlight TAP-dependent
in mean fluorescence were selected and the frequencies influences. In agreement with the previous data, Gln,
of each amino acid at each position in the peptide calcu- Leu, and Met resolved as anchor residues at cycle 2
lated. These were then compared with the frequencies (Figure 2). The amounts of Gln and Leu recovered in
of each amino acid at each position in the total panel of cycle 2 consistently differed between the two rat strains,
9-mer peptides (Figure 1). The most striking observation
with TAP2B±RT1.Aa peptides containing Gln more often
occurred at P9, where there was a 5-fold increase in the
than Leu (Figure 2B), whereas TAP2A±RT1.Aa-derived
frequency of Arg, such that 50% of the peptides in the
peptides contained Leu more often than Gln (Figure 2A).
positive binding subset contained this residue at the C
In cycle 3, increases were also observed for Phe andterminus. Lys, however, did not show a similarly dra-
Asn. However, the main TAP allotype-dependent differ-matic increase, suggesting a strong preference in the
ences in the pool sequences occurred at cycles 7±9.C-terminal binding pocket for Arg over Lys. At P2, the
The TAP2A-derived peptides contained Arg at cyclesfavored residues were the hydrophobic Met, Val, Ile, and
8 and 9, suggesting that the peptide pool containedalso, conspicuously, the hydrophilic residue Gln. The
a mixture of 8- and 9-mer peptides bearing a C-termi-model-predicted P2 Leu (Thorpe et al., 1995) showed
nal Arg. In contrast, the TAP2B-dependent sequenceonly a modest relative excess in this position. The re-
showed increases at cycle 7 for Arg and Glu (and, inmaining notable increases occurred at P7 with high fre-
some experiments, His), no Arg increase at cycle 8, andquencies of the charged residues Glu and Arg, a feature
a small increase in Arg at cycle 9 (Figure 2B, underlined).not previously established in the molecular modeling
The absence of any other cycle 9 anchor signal couldstudies. Of those peptides that possess P7 Glu or Arg,
suggest the presence of a population of shorter 7-merthree quarters also have Gln, Met, or a small hydropho-
bic residue at P2. Thus, the data from the in vitro assay peptides terminating in Arg or Glu, but we have observed
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Figure 2. Sequence Analysis of RT1.Aa-Derived Peptide Pools from TAP2A and TAP2B Spleens
(A) TAP2A spleens.
(B) TAP2B spleens.
HPLC-purified peptides from immunoaffinity-isolated RT1.Aa molecules were pooled and sequenced by Edman degradation. Significant
increases in picomole yield, as described in Experimental Procedures, are highlighted in boxes. The basic RT1.Aa peptide binding motif is
summarized in (C) for TAP2A cells and (D) for TAP2B cells. Anchor residues are indicated in bold; other residues displaying increases are
shown in small capitals.
that synthetic Arg-ended 7-mer peptides do not effi- Glu being prominent only in peptides supplied by
TAP2B.ciently stabilize RT1.Aa in the in vitro assay already de-
scribed (L. L. Y., unpublished data). Alternatively, the Edman degradation of natural peptide pools is limited
by the difficulty in assigning C-terminal residues in mix-weaker cycle 8 and 9 signals seen in the TAP2B-associ-
ated peptide pools may reflect a population of peptides tures where peptide length is not fixed. To investigate
directly the difference in C-terminal residues from thelonger than 7-mers with positions 8 and 9 occupied by
a variety of different amino acids. The motif obtained two peptide pools, we made use of anhydrotrypsin as
an affinity matrix for Arg- and Lys-ended peptides (Yoko-using the in vitro stabilization assay therefore appears
to be a combination of the two in vivo TAP2-dependent sawa and Ishii, 1979). In this chemically modified deriva-
tive of trypsin the activesite serine residue is modified tomotifs. The in vitro data indicates a role for P7 in peptide
binding alongside that of P2 and the C-terminal anchor dehydroalanine, resulting in a catalytically inert product
that retains the capacity, under weakly acidic condi-residues, whereas the in vivo data apparently splits the
role of P7 and the C-terminal residue, with P7 Arg and tions, to bind peptides with C-terminal Arg (and, with
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We conclude, therefore, that there cannot be a large
population of Arg-ended 7-mers, as might be inferred
from the pooled peptide sequence data from cimb cells
(see Figures 2B and 2D), but probably a population of
longer peptides ending in a residue other than Arg. Our
data cannot, however, exclude the presence of some
Glu-ended 7-mer peptides, which would fail to bind an-
hydrotrypsin±agarose.
We finally investigated whether the prolonged ER re-
tention of RT1.Aa in cimb cells (Powis et al., 1991b) could
be ascribed to the negatively charged environment of
the peptide C-terminal binding pocket. We constructed
site-directed mutants of RT1.Aa designed to reduce the
net negative charge in the C-terminal binding pocket.
The mutants Asp77Asn and Glu97Val were designed to
alter the C-terminal binding pocket towards that of the
RT1.Au allele (Joly et al., 1995), the assembly rate of
which is known to be cim independent. Wild-type
RT1.Aa, and the site-directed mutagenesis variants,
were expressed in a cimb cell line (derived from a
BN,RT1n haplotype rat; Williams et al. 1980). Since
RT1.Au matches RT1.Aa in possession of Asp116, muta-
genesis of this residue was not performed for this study.
As shown in Figure 4, removal of the negative charge
from Asp77, Glu97, or both residues led to an accelera-
tion in the maturation of glycans as seen in pulse±chase
profiles of the mutants relative to the slow wild-type
RT1. Aa, showing that these mutant molecules leave theFigure 3. Analysis of C-Terminal Residues in Peptides Eluted from
ER more rapidly than the wild type in a cimb host, andRT1.Aa Using Immobilized Anhydrotrypsin
thus further implicating the residues lining this pocketHPLC traces of control samples not subjected to anhydrotrypsin±
agarose chromotography are shown for (A) TAP2A cells and (B) in the cim phenomenon.
TAP2B cells. Peptides not binding to the anhydrotrypsin±agarose
at pH 5.0 (C and D, unbound) and those subsequently eluted at
pH 2.5 (E and F, bound) demonstrate the presence of Arg-ended Discussion
peptides from TAP2A but not TAP2B cells.
The data presented here explain the main aspects of
the cim phenomenon, which strongly affects the biosyn-weaker affinity, Lys). It fails to bind free amino acids,
dipeptides, or peptides with other residues at the C thetic and immunological behavior of RT1.Aa in vivo.
Recent assessments of TAP transporter function usingterminus. This specificity allows anhydrotrypsin, once
immobilized on a support, tobe used as an affinity matrix synthetic peptides in in vitro assay systems have indi-
cated that rat TAP2B-containing transporters do noton which to absorb (and elute) Arg-ended MHC-derived
peptides. Concanavalin A±activated lymphoblasts were efficiently transport peptides that possess charged or
polar C-terminal residues (Momburg et al., 1994;labeled with [3H]Leu, the RT1.Aa molecules immunopre-
cipitated, and peptides extracted by acidification and Heemels et al., 1993; Heemels and Ploegh, 1994). As
demonstrated here, RT1.Aa strongly favors the presenceisolation of a low molecular mass pool. Of each sample,
50% was directly analyzed by reverse-phase high pres- of Arg in its peptide C-terminal pocket. Indeed, it seems
likely from the remarkably acidic molecular environmentsure liquid chromatography (HPLC), and produced the
previously described observation (Powis et al., 1992) in the C-terminal pocket that this preference for a posi-
tively charged C-terminal residue may be stronger thanof early eluting peaks from cima (TAP2A) RT1.Aa cells,
whereas cimb (TAP2B) RT1.Aa cellsproduced peaks elut- in the case of HLA-B27, which can also bind peptides
terminating in hydrophobic residues such as Leu or Valing later (Figures 3A and 3B). The remaining 50% of
each sample was applied to an anhydrotrypsin±agarose (RoÈ tzschke et al., 1994). As a consequence, in cimb cells
that carry the TAP2B allele, RT1.Aa faces starvation ofcolumn. Material passing through the column was col-
lected, as was material subsequently eluted at pH 2.5. an optimal peptide subset. In contrast, in cima cells there
exists an adequate supply of Arg-ended peptides toThese samples were also analyzed by reverse-phase
HPLC (Figures 3C±3F). In the cima±RT1.Aa peptide pool, satisfy the requirements of RT1.Aa, and the completed
class I molecule can then exit the ER binding compart-virtually all the recoverable counts were bound to the
column and subsequently eluted at pH 2.5, indicating ment at a normal rate. We have also used site-directed
mutagenesis to change the residues implicated in fa-the presence of a substantial peptide pool possessing
a C-terminal Arg residue as predicted (see Figures 2A voring C-terminal Arg in RT1.Aa to those carried by an
RT1.A allele whose behavior is apparently unaffectedand 2C). In contrast, the cimb±RT1.Aa peptides failed to
bind to the anhydrotrypsin column, indicating that these by cim. The results, which showed that mutagenesis of
Asp77, Glu97, or both brought about a relaxation of thepeptides do not have Arg or Lys as a C-terminal residue.
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Figure 4. Pulse±Chase Analysis of Site-
Directed Mutants of RT1.Aa
In TAP2A cells (rat 2 cells, top left panel) the
RT1.Aa heavy chain displays rapid glycan
maturation, whereas in TAP2B cells (BN leu-
kemia, top middle panel) the heavy chain
matures slowly. Modification of negatively
charged residues in the C-terminal binding
pocket relieves the retention phenotype in
TAP2B cells as shown in the bottom three
panels. The fast maturation of wild-type
RT1.Au in TAP2B cells is illustrated in the top
right panel.
Wild-type RT1.Au, RT1.Aa, and the indicated mutagenized variants of the RT1.Aa peptide C-terminal binding pocket were immunoprecipitated
from 35S-labeled cells at chase timepoints of 0, 30, and 90 min. The first track of each panel represents precipitation in the presence of an
irrelevant anti-class I MAb. Only the heavy chain is shown, but in all instances b2-microglobulin coprecipitated with the heavy chain.
characteristic long ER retention of RT1.Aa when ex- (Powis et al., 1991b), presumably owing topeptide short-
age, and even then the proportion of bound Arg-endedpressed in homozygous cimb cells, were consistent with
the model for C-terminal Arg binding proposed (Thorpe peptides is low (Figure 3), it is difficult to escape the
conclusion that the Arg C termini of peptides normallyet al., 1995). We interpret this relaxation of the ER reten-
tion phenotype as being due to the ability of the mutants loaded into RT1.Aa in cima cells are formed by proteolytic
activity in the cytosol and not in the ER. The same con-to bind peptide C termini that can be transported by
TAP2B containing transporters. Interestingly, RT1.Au clusion may be derived from studies in which a Kd-
restricted peptide with a dipeptide extension from itspossesses Asp116 in common with RT1.Aa, yet this
alone is clearly not sufficient to predispose it to the cim- canonical C terminus could not apparently be processed
despite normal TAP-dependent transport into the ERdependent effects seen for RT1.Aa, since RT1.Au has a
fast pulse±chase phenotype in TAP2B cells. It is there- (Eisenlohr et al., 1992), and by the failure of TAP2/2 mice
to present an epitope containedwithin the signal peptidefore the unusually strong negative charge characteristic
of the pocket in RT1.Aa that causes this class I product of a lymphocytic choriomeningitis virus glycoprotein
(Hombach et al., 1995). In contrast, the report by Elliottto be incompatible with the limited set of peptides avail-
able in cimb cells. and colleagues (1995) that the correct C-terminal resi-
due could be exposed from a 170 residue long influenzaThe peptide subsets bound by RT1.Aa in the context
of the two TAP2 allotypes are thuswidely different, caus- nucleoprotein fragment carrying a signal peptide, and
evidence that HIV gp120 with a signal peptide could being an alloantigenic disparity that permits the generation
of alloreactive cytotoxic T cells between rat strains that processed and presented normally through HLA-A3.1
in TAP-deficient T2 cells, are both apparently at varianceboth express RT1.Aa but possess different TAP2 alleles
(Livingstone et al., 1989). In the face of a paucity of with this conclusion (Hammond et al., 1993) However,
in T2 and other TAP-deficient lines, it is difficult to distin-peptides with the appropriateC-terminal residue, RT1.Aa
develops a new peptide motif pattern. P7-Arg and Glu guish between a marginal process and one that is insig-
nificant in the normal case, since in such cells class Imay not be critical in peptides carrying C-terminal Arg,
but may become essential compensatory anchors in loading is not occurring in competition with the normal
TAP-dependent flux of peptides from the ER. Our resultsits absence. Thus, our data both validate, in vivo, the
published in vitro TAP transport assays, and provide suggest that new C termini are not normally formed at
significant levels in the ER class I loading compartment.clear evidence of the impact of the selective transport
detected in those studies (Momburg et al., 1994; Finally, at theexperimental level, our introduction here
of anhydrotrypsin for the analysis of MHC bound pep-Heemels et al., 1993; Heemels and Ploegh, 1994). The
original characterization of the cim effect on RT1.Aa in- tides is likely to prove useful in the study of the relative
contributions of Arg and Lys C-terminal peptides boundcluded use of the monoclonal antibody (MAb) JY3/84,
which has the capacity to distinguish, albeit weakly, by other bivariate class I alleles in which conditions
controlling thechoice of positively charged or hydropho-between RT1.Aa expressed on cima (good JY3/84 bind-
ing) or cimb (poor binding) cells (Livingstone et al., 1989, bic peptide C termini are not fully understood.
1991). With appropriately designed synthetic peptides
it will now be possible to use RMA-S cells expressing Experimental Procedures
RT1.Aa to determine whether any of the TAP allele-
induced changes in the bound peptides influence RT1.Aa Peptide Stabilization Assay
JY3/84 binding. Overlapping (467, and 105 variant sequence) peptides from the hu-
man papilloma virus (HPV) strains 16 and 18 E6 and E7 proteins,Our data argue against an important role for protease
and 22 HPV 16 non-E6/E7-derived peptides, to which were addedactivity in the ER as a means by which the definitive C
15 peptides from the murine p53 polypeptide and 33 from folinetermini of class I±loaded peptides are derived from
binding protein, were tested in an assay based on that of Feltkamplonger precursor peptides. Both trypsin-like endo- and
et al. (1993). RMA-S cells expressing a cDNA for RT1.Aa (Rada et
carboxyl-peptidases, if present in the ER, could reveal al., 1989; Powis et al., 1993) were incubated overnight at 268C. Cells
Arg C termini from longer peptides. But since RT1.Aa is were then washed, counted, and dispensed into 96-well plates at
2.5 3 105 cells per well in serum-free RPMI. Peptides were addedretained in the ER at least ten times longer in cimb cells
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to a final concentration of 50 mM. After a 4 hr incubation at 378C to onto 1.0 cm GF/D glass fiber discs (Whatman), dried, and the pres-
ence of 3H determined by liquid scintillation counting. The relativeallow dissociation of the nonpeptide-stabilized class I molecules,
the plates were washed once with phosphate-buffered saline (PBS) absence of some peaks from the central portion of Figure 4E may
possibly be accounted for by high affinity binding to the matrix,containing 0.5% bovine serum albumin, and stained for FACS analy-
sis with first stage anti-RT1.Aa MAbs (AFRC MAC 30 or MAC210; since some further counts can be stripped from the column with 6
M urea (data not shown).Butcher 1987) and second stage fluorescein isothiocyanate±
conjugated rabbit anti-rat immunoglobulin (DAKO). Cells were ana-
lyzed on a FACScan (Becton Dickinson) and the mean fluorescence
Site-Directed Mutagenesis of RT1.Aaindex (MFI) for each peptide calculated as the following:
The cDNA encoding RT1.Aa (Rada et al., 1989) was subcloned into
pAlter (Promega) as a 1.1 kb BamHI fragment and mutagenizedMean Fluorescence (MF) Index 5
using the altered sites mutagenesis system kit (Promega). The muta-
genizing oligonucleotides were the following: for position 77 Asp to(MF with peptide)2(MF without peptide)
(MF without peptide) Asn, 59-GATTTACCGAGTGAACCTGAGGACCC-39 and for position
97 Glu to Val, 59-CACACCATCCAGGTGATGTATGGCTGT-39. A mix
of the two was used for the double mutation. Mutations were verifiedThe Sendai virus peptide FAPGNYPAL was used as a positive
by direct sequencing of the plasmids.control for the endogenous H-2Kb class I molecule and at 50 mM
gave a MFI of 4.65 compared with the maximum 3.40 achieved for
RT1.Aa. Data shown in Figure 2 represents the top 50 binding pep- Retroviral Expression of cDNAs
tides in three separateexperiments that gave an average MFI greater The cDNAs for RT1.Aa and its mutagenized derivatives, as well as
than 0.55. Variant sequence peptides are those peptides containing for RT1.Au (Joly et al., 1995) were cloned in the BamHI site of the
Cys that were also included in the assay resynthesized with Ala pLXLJ vector, and transfected into E2 cells as described previously
substitutions. for the H2-Db cDNA (Joly and Oldstone, 1992) Supernatants from
To assess the possibility of bias towards any amino acids in the the various G418-resistant Y2 cells were then used to infect BN
HPV polypeptides, the percentage of each amino acid present (of (RT1n, cimb) leukemia cells and rat 2 fibroblasts (RT1lv1, cima) After
the 519 residues in total) were compared with those present in the selection with G418, the surviving cell populations were all found
Swissprot database (26 3 106 aa in total). The percentage for each to express the transfected RT1.A molecules with frequencies in
aminos acid are (HPV followed by Swissprot in parentheses); excess of 90%.
Ala 3.9 (7.6), Cys 7.3 (1.7), Asp 6.4 (5.3), Glu 7.7(6.3), Phe 3.1(4.0),
Gly 2.9 (6.9), His 4.2 (2.2), Ile 4.6 (5.7), Lys 4.6 (5.9), Leu 11.2 (9.3),
Pulse±Chase AnalysisMet 1.9 (2.4), Asn 3.3 (4.5), Pro 4.8(4.9), Gln 6.4 (4.0), Arg 8.7 (5.2),
Pulse±chases were performed as previously described (Powis etSer 4.4 (7.2), Thr 6.0 (5.8), Val 4.0 (6.5), Trp 0.3 (1.3), Tyr 4.2 (3.2).
al., 1991b) using MAbs conjugated to protein A±Sepharose with
dimethylpimelimidate (Harlow and Lane, 1988). RT1.Aa and RT1.AuSequencing of RT1.Aa-Derived Peptide Pools
were immunoprecipitated with MAbs MAC30 and NR5/10, respec-Peptide pools were prepared essentially as described by Falk et al.
tively (Butcher, 1987).(1991). In brief, cell suspensions from 20 spleens of TAP2A (PVG-
RT1av1 [DA]) and TAP2B (PVG.R1) rats were lysed in 200 ml lysis
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